You are here

Safety, Efficacy, and Pharmacokinetic Bioequivalence of Biosimilar Tumor Necrosis Factor-Alpha Inhibitors Compared with Their Reference Biologics: A Systematic Review

Value in Health, Volume 19, Issue 3, May 2016, Page A226

Footnotes

1 Johns Hopkins Bloomberg School of Public Health, Center for Drug Safety and Effectiveness, Baltimore, MD, USA

2 Johns Hopkins University, Baltimore, MD, USA

3 Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA